melatonin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
melatonin — no detected effect on HOMA-IR
Evidence strength: moderate.FindingNull resultreplicated ×1“There were no intergroup differences in CAVI, mtDNA, HOMA-IR, or SBP from the baseline to week six between the placebo and melatonin groups.”
Quoted verbatim from Melatonin Supplementation for Six Weeks Had No Effect on Arterial Stiffness and Mitochondrial DNA in Women Aged 55 Years and Older with Insomnia: A Double-Blind Randomized Controlled Study.. - Study
- RCT
- Duration
- 6 weeks
- Dose
- 2 mg prolonged-release melatonin (Circadin 2 mg PR) once a day, two hours before sleep, for six weeks
- Population
- Women aged 55 years and older with insomnia (PSQI of 5 or more), untreated; change from baseline to week six
Melatonin Supplementation for Six Weeks Had No Effect on Arterial Stiffness and Mitochondrial DNA in Women Aged 55 Years and Older with Insomnia: A Double-Blind Randomized Controlled Study.2021PMID:3380652910.3390/ijerph18052561Permalink
To cite this finding: https://catalystproject.ai/e/01M5JXWN6EQM13V3ZNTVT7YWWZ